A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...
A new blood test that combines four protein biomarkers can detect early-stage pancreatic cancer with nearly 88% accuracy, ...
PanMETAI combines AI and NMR metabolomics to detect early-stage pancreatic cancer from a blood sample, achieving 93 percent ...
Pivotal study shows no clear benefit for the common endoscopic procedure in this patient group. Experts say the new data ...
Currently, no consensus exists regarding the definition of oligometastatic pancreatic ductal adenocarcinoma, its necessary diagnostic measures, and potential treatment approaches. To address these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results